Clinical Trial Update: Clinical Efficacy and Safety Evaluation of Teneligliptin in Type 2 Diabetes Who Have Inadequate GlycemIc Control With Empaglyflozin 25 mg and Metformin [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating Teneligliptin added to Empagliflozin 25 mg and Metformin in Type 2 diabetes mellitus with inadequate glycemic control has completed. …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Empagliflozin (empagliflozin)
• Teneligliptin (Teneligliptin)
• metformin (metformin)

Snippet

Sponsor: Handok Inc. | Conditions: Type 2 Diabetes | Phase 3 | Status: COMPLETED